Back
Adaptimmune Therapeutics PLC Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
4
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
50.57%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.75 | Sell |
| 20-day SMA: | 0.76 | Sell |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.13 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.77 | Sell |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 1.01 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 26.27 | Sell |
| Chaikin Money Flow: | -2051103 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.7 - 0.86) | Sell |
| Bollinger Bands (100): | (0.83 - 1.21) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 0.59 while ADAP 8-day simple moving average is 0.75, which is a Sell signal.
- The stock price of ADAP is 0.59 while Adaptimmune Therapeutics PLC 20-day SMA is 0.76, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day simple moving average is 0.88 while ADAP share price is 0.59, making it a Sell technically.
- ADAP stock price is 0.59 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.13, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
4
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a Sell
The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.59. The Score for ADAP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
150.1M
Price in USD:
0.59
Share Volume:
3.39M
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
2.05
52-Week Low:
0.42
Sell
4
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?
The Adaptimmune Therapeutics PLC stock price is 0.59 USD today. -
Will ADAP stock go up or go down?
Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Adaptimmune Therapeutics PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
- Adaptimmune Therapeutics PLC share price is 0.59 while ADAP 8-day exponential moving average is 0.71, which is a Sell signal.
- The stock price of ADAP is 0.59 while Adaptimmune Therapeutics PLC 20-day EMA is 0.77, which makes it a Sell.
- Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.87 while ADAP share price is 0.59, making it a Sell technically.
- ADAP stock price is 0.59 and Adaptimmune Therapeutics PLC 200-day simple moving average is 1.01, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.33 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
- ADAP Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Adaptimmune Therapeutics PLC is a Sell
- Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 26.27, which suggest Adaptimmune Therapeutics PLC is oversold
- The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.7 - 0.86), which suggest Adaptimmune Therapeutics PLC is a Sell
- The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.83 - 1.21), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.